This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Kangrun Pharmaceuticals Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations of Xiaodong Wang in Pharmaceutical Synthesis
Introduction
Xiaodong Wang is a notable inventor based in Wujiang, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly through his innovative work on azaphenalene-3-one derivatives. His research focuses on developing compounds that have potential applications in anti-tumor drug research.
Latest Patents
Xiaodong Wang holds a patent for an azaphenalene-3-one derivative, which includes a preparation method and its applications. This derivative is characterized by a specific formula where R can be various chemical groups, including H, 2-fluoroethylamino, and others. The preparation method is noted for its simplicity, high yield, and ease of post-treatment, resulting in high purity. Importantly, this derivative exhibits significant inhibitory activity against the PARP enzyme, laying the groundwork for the development of more effective anti-tumor drugs utilizing PARP inhibitors.
Career Highlights
Xiaodong Wang is currently associated with Suzhou Kangrun Pharmaceuticals Inc., where he continues to advance his research in pharmaceutical innovations. His work has garnered attention for its potential impact on cancer treatment and drug development.
Collaborations
Xiaodong collaborates with esteemed colleagues, including Hao Zhang and Weiliang Xu, who contribute to his research endeavors and help enhance the scope of his innovative projects.
Conclusion
Xiaodong Wang's contributions to pharmaceutical synthesis through his patented azaphenalene-3-one derivative highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile